This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Elite Laboratories, Inc.
Elite Laboratories, Inc., commonly referred to as Elite Pharma, is a leading player in the pharmaceutical industry, headquartered in the United States. Founded in 2002, the company has established a strong presence in key operational regions across North America and Europe, focusing on the development and manufacturing of high-quality generic and specialty pharmaceuticals. Elite Laboratories is renowned for its innovative approach to drug formulation and delivery systems, offering a diverse portfolio that includes oral solids, injectables, and topical products. Their commitment to quality and compliance has positioned them as a trusted partner in the healthcare sector, achieving notable milestones such as FDA approvals and successful collaborations with major pharmaceutical companies. With a reputation for excellence, Elite Laboratories continues to advance its mission of improving patient outcomes through effective and accessible medication solutions.
DitchCarbon Score
How does Elite Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elite Laboratories, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elite Laboratories, Inc.'s reported carbon emissions
Elite Laboratories, Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is identified as a current subsidiary and does not inherit emissions data from a parent organisation. In terms of climate commitments, Elite Laboratories, Inc. has not established any documented reduction targets or initiatives, including those aligned with the Science Based Targets initiative (SBTi). The absence of a climate pledge or specific reduction strategies indicates that the company may still be in the early stages of developing its climate action framework. As a subsidiary, Elite Laboratories, Inc. may benefit from broader corporate sustainability initiatives from its parent company, but specific details on such initiatives are not provided. The company’s future climate commitments and emissions reporting will be crucial for aligning with industry standards and addressing global climate challenges.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elite Laboratories, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
